T H Tan
Clinical Oncology Society of Australia Annual Scientific Meeting 2019
Days
Monday, 11th November
Tuesday, 12th November
Wednesday, 13th November
Thursday, 14th November
Search
Speakers
T H Tan
Abstracts this author is presenting:
Analysis of overall survival (OS) based on early tumour shrinkage in the phase 3 METEOR study of cabozantinib (cabo) versus everolimus (eve) in advanced renal cell carcinoma (RCC)
—
Poster Session 2